Asia-Pacific markets mixed following losses on Wall Street; Bank of Japan meeting in focus

Asia-Pacific markets mixed following losses on Wall Street; Bank of Japan meeting in focus


© Marco Bottigelli | Moment | Getty Images

Asia-Pacific markets traded mixed on Wednesday, following declines on Wall Street after a sell-off in technology stocks picked up pace.

Japanese markets will be in focus for investors, with the Bank of Japan poised to announce its monetary policy decision later in the day. The central bank is widely expected to hold interest rates steady at 0.5%.

Japan’s benchmark Nikkei 225 edged up 0.41% shortly after the open, while the broader Topix index increased 0.70%.

Over in South Korea, the Kospi index started the day 0.91% higher, while the small-cap Kosdaq fell 0.27% in choppy trade.

Australia’s S&P/ASX 200 pared losses to trade 0.13% lower.

Futures for Hong Kong’s Hang Seng index stood at 24,716, pointing to a slightly weaker open compared to the HSI’s close of 24,740.57.

Overnight in the U.S., stocks were back in the red after two straight winning sessions.

The Dow Jones Industrial Average lost 260.32 points, or 0.62%, closing at 41,581.31. The S&P 500 shed 1.07%, ending at 5,614.66. The broad market index concluded the day 8.6% off its closing high reached in February, bringing it near correction territory. The Nasdaq Composite dropped 1.71% and settled at 17,504.12.

Tesla, one of the stocks hardest hit during the market’s recent correction, was down yet again on Tuesday. The stock fell more than 5% after RBC Capital Markets lowered its price target on the electric vehicle name, given stiff competition in the EV space.

Elsewhere, shares of Palantir and Nvidia dropped nearly 4% and more than 3%, respectively. The Technology Select Sector SPDR Fund (XLK) was also down more than 1%.

— CNBC’s Sean Conlon and Alex Harring contributed to this report.



Source

Ozempic maker Novo Nordisk lowers growth outlook for its weight loss drugs as pricing pressures mount
World

Ozempic maker Novo Nordisk lowers growth outlook for its weight loss drugs as pricing pressures mount

A box of Ozempic sits on a table in North Tyneside, Britain, Oct. 31, 2023. Lee Smith | Reuters Danish pharmaceutical giant Novo Nordisk said Wednesday it is trimming its growth expectations for its leading obesity and diabetes treatments as competition intensifies and pricing pressures mount in the weight loss market. Net profit for the […]

Read More
Europe to open lower as markets question tech valuations; Novo Nordisk earnings ahead
World

Europe to open lower as markets question tech valuations; Novo Nordisk earnings ahead

European stocks are expected to open lower, mirroring global declines as concerns grow over sky-high tech valuations. Source

Read More
California voters approve new U.S. House map to boost Democrats in 2026
World

California voters approve new U.S. House map to boost Democrats in 2026

California voters approved new congressional district boundaries Tuesday, delivering a victory for Democrats in the state-by-state redistricting battle that will help determine which party wins control of the U.S. House in 2026 and, with it, the power to thwart or advance President Donald Trump’s agenda. The approval of Proposition 50 gives Democrats a shot at […]

Read More